Vaccine to treat Alzheimer’s patients progresses to next stage of trials
A vaccine which could be used to treat patients with Alzheimer’s disease has reached the next stage of clinical trials. ACI-24, developed by Swiss-based pharmaceutical company AC Immune, will be
Read More